<DOC>
	<DOCNO>NCT03100240</DOCNO>
	<brief_summary>NF-κB pathway activation-induced endometrial insulin resistance one cause infertility patient PCOS insulin resistance whose endometrial receptivity decline .The investigator ' previous finding indicate use modify utral-long protocol ( GnRH-a use twice mid-luteal phaes ) improve clinical outcome improve endometrial receptivity patient PCOS , mechanism clear . Previous research also find GnRH-a reduced activity NF-κB pathway endometrial stromal cell depend dose time.Thus , The investigator ' subject try applicate GnRH-a explore influence NF-κB pathway activity 、the state insulin resistance embryo implantation rate ; investgate GnRH-a whether reduce NF-κB pathway activity-induced insulin resistance ultimately improve endometrial receptivity use GnRH-a infertility patient PCOS insulin resistance.The investigator ' research attempt provide idea seek inflammatory medication target assist reproductive technology patient PCOS explore immune mechanism GnRHa improve endometrial receptivity .</brief_summary>
	<brief_title>The Mechanism Modified Utral-long Protocol Improving Endometrial Receptivity Patients With PCOS IR</brief_title>
	<detailed_description>The endometrial biopsy perform previous cycle protocol . According expression NF-κB endometrium random group . The difference NF - κB expression patient different protocol compare .</detailed_description>
	<criteria>age＜36years , PCOS , Insulin resistance ( HOMAIR = fast insulin ( FINS ) × fast blood glucose ( FPG ) / 22.5 , HOMAIR ≥ 2.69 ） ; uterine abnormality ( double uterus , bicornuate uterus , unicornuate uterus uterine mediastinum ) , intrauterine adhesion , endometriosis , adenomyosis , Hydrosalpinx , uterine fibroid ( submucosal fibroid , nonmucosal fibroid &gt; 4 cm / endometrial pressure ) , Hyroid dysfunction hyperprolactinemia .</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>